4//SEC Filing
Newman Stephen L 4
Accession 0001209191-13-016902
CIK 0001333248other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:44 PM ET
Size
5.4 KB
Accession
0001209191-13-016902
Insider Transaction Report
Form 4
Newman Stephen L
Director
Transactions
- Award
Stock option (right to buy)
2013-03-13+37,500→ 37,500 totalExercise: $5.40Exp: 2023-03-13→ common stock (37,500 underlying)
Footnotes (2)
- [F1]Shares shall vest in thirty-six equal monthly installments on the first day of each calendar month subsequent to the date of grant, subject to such director's continuing service on our board of directors on those dates.
- [F2]Not applicable to this transaction.
Documents
Issuer
CADENCE PHARMACEUTICALS INC
CIK 0001333248
Entity typeother
Related Parties
1- filerCIK 0001384061
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 4:44 PM ET
- Size
- 5.4 KB